Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Phibro Animal Health (PAHC) Accumulated Depreciation & Amortization (2016 - 2025)

Phibro Animal Health has reported Accumulated Depreciation & Amortization over the past 13 years, most recently at $279.0 million for Q2 2025.

  • For Q2 2025, Accumulated Depreciation & Amortization rose 13.7% year-over-year to $279.0 million; the TTM value through Jun 2025 reached $279.0 million, up 13.7%, while the annual FY2025 figure was $279.0 million, 13.7% up from the prior year.
  • Accumulated Depreciation & Amortization for Q2 2025 was $279.0 million at Phibro Animal Health, up from $245.4 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $279.0 million in Q2 2025 and troughed at $223.1 million in Q2 2021.
  • A 5-year average of $250.4 million and a median of $245.4 million in 2024 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: dropped 6.93% in 2024 and later increased 13.7% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $223.1 million in 2021, then rose by 8.03% to $241.0 million in 2022, then rose by 9.4% to $263.6 million in 2023, then fell by 6.93% to $245.4 million in 2024, then increased by 13.7% to $279.0 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for PAHC at $279.0 million in Q2 2025, $245.4 million in Q2 2024, and $263.6 million in Q2 2023.